1. Home
  2. BEAM vs USA Comparison

BEAM vs USA Comparison

Compare BEAM & USA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BEAM
  • USA
  • Stock Information
  • Founded
  • BEAM 2017
  • USA 1986
  • Country
  • BEAM United States
  • USA United States
  • Employees
  • BEAM N/A
  • USA N/A
  • Industry
  • BEAM Biotechnology: Biological Products (No Diagnostic Substances)
  • USA Finance Companies
  • Sector
  • BEAM Health Care
  • USA Finance
  • Exchange
  • BEAM Nasdaq
  • USA Nasdaq
  • Market Cap
  • BEAM 1.9B
  • USA 2.0B
  • IPO Year
  • BEAM 2020
  • USA N/A
  • Fundamental
  • Price
  • BEAM $27.50
  • USA $7.44
  • Analyst Decision
  • BEAM Buy
  • USA
  • Analyst Count
  • BEAM 11
  • USA 0
  • Target Price
  • BEAM $45.90
  • USA N/A
  • AVG Volume (30 Days)
  • BEAM 1.2M
  • USA 880.5K
  • Earning Date
  • BEAM 11-05-2024
  • USA 01-01-0001
  • Dividend Yield
  • BEAM N/A
  • USA 9.66%
  • EPS Growth
  • BEAM N/A
  • USA N/A
  • EPS
  • BEAM N/A
  • USA N/A
  • Revenue
  • BEAM $349,643,000.00
  • USA N/A
  • Revenue This Year
  • BEAM N/A
  • USA N/A
  • Revenue Next Year
  • BEAM $6.04
  • USA N/A
  • P/E Ratio
  • BEAM N/A
  • USA N/A
  • Revenue Growth
  • BEAM 328.73
  • USA N/A
  • 52 Week Low
  • BEAM $20.84
  • USA $5.62
  • 52 Week High
  • BEAM $49.50
  • USA $7.09
  • Technical
  • Relative Strength Index (RSI)
  • BEAM 59.14
  • USA 66.57
  • Support Level
  • BEAM $21.46
  • USA $7.00
  • Resistance Level
  • BEAM $32.29
  • USA $7.19
  • Average True Range (ATR)
  • BEAM 1.86
  • USA 0.08
  • MACD
  • BEAM 0.64
  • USA 0.03
  • Stochastic Oscillator
  • BEAM 55.77
  • USA 94.68

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201.

About USA Liberty All-Star Equity Fund

Liberty All Star Equity Fund is a closed-end funds and open-end multi-managed fund. Its objective is to provide a high level of current income and long-term capital appreciation through investing primarily in a diversified portfolio of equity securities. The fund invests in various sectors, including financials, information technology, healthcare, consumer discretionary, consumer staples, industrials, energy, materials, real estate, utilities, telecommunication and other services.

Share on Social Networks: